Olga R Ilkayeva Selected Research

Obesity

1/2022	Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome.
1/2019	BCAA catabolism in brown fat controls energy homeostasis through SLC25A44.
1/2019	Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles.
12/2018	Cord Blood Metabolites Associated with Newborn Adiposity and Hyperinsulinemia.
10/2015	Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans.
5/2015	Metabolomic analysis reveals altered skeletal muscle amino acid and fatty acid handling in obese humans.
6/2014	Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.
4/2014	Obesity and lipid stress inhibit carnitine acetyltransferase activity.
1/2012	Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation.
7/2005	Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olga R Ilkayeva Research Topics

Disease

12	Insulin Resistance 02/2024 - 12/2009
10	Obesity 01/2022 - 07/2005
4	Birth Weight (Birth Weights) 03/2023 - 01/2017
3	Hyperglycemia 03/2023 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
3	Heart Failure 11/2020 - 01/2014
3	Inflammation (Inflammations) 01/2020 - 01/2012
3	Hypoxia (Hypoxemia) 07/2018 - 06/2015
3	Neoplasms (Cancer) 01/2016 - 03/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2012
2	Fibrosis (Cirrhosis) 01/2021 - 08/2018
2	Hyperinsulinism (Hyperinsulinemia) 12/2018 - 07/2005
2	Glucose Intolerance 04/2017 - 05/2015
2	Infections 11/2016 - 09/2015
2	Fatty Liver 01/2012 - 07/2005
2	Hypoglycemia (Reactive Hypoglycemia) 12/2010 - 03/2007
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Dementia (Dementias) 01/2023
1	Hypothermia 12/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Prediabetic State (Prediabetes) 10/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Ketosis 11/2020
1	Atherosclerosis 01/2020
1	Rheumatoid Arthritis 01/2019
1	Weight Loss (Weight Reduction) 08/2018
1	Breast Neoplasms (Breast Cancer) 07/2018
1	Ischemia 01/2017
1	Dengue (Dengue Fever) 11/2016
1	Yellow Fever 11/2016
1	Overweight 10/2015

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 07/2005
8	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2012
8	LipidsIBA 01/2020 - 12/2009
7	Insulin (Novolin)FDA Link 02/2024 - 03/2007
7	Triglycerides (Triacylglycerol)IBA 03/2023 - 07/2005
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
5	Amino Acids FDA Link 01/2020 - 05/2015
4	C-PeptideIBA 03/2023 - 01/2019
3	Branched-Chain Amino AcidsIBA 10/2019 - 10/2015
3	N-methyladenosineIBA 07/2018 - 11/2016
3	6-methyladenineIBA 07/2018 - 11/2016
3	Carnitine (L-Carnitine)FDA LinkGeneric 01/2017 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 11/2016 - 01/2014
2	KetonesIBA 11/2020 - 01/2020
2	CarbohydratesIBA 11/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	Leucine (L-Leucine)FDA Link 01/2019 - 04/2017
2	acylcarnitineIBA 12/2018 - 09/2015
2	LeptinIBA 12/2018 - 03/2010
2	CholesterolIBA 01/2018 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2017 - 06/2015
2	RNA (Ribonucleic Acid)IBA 01/2017 - 11/2016
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017 - 03/2009
2	CarbonIBA 11/2014 - 03/2009
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	KynurenineIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	ProteomeIBA 01/2022
1	NAD (NADH)IBA 12/2021
1	Sirtuin 1IBA 12/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	RotenoneIBA 01/2021
1	OxidesIBA 01/2021
1	Monocarboxylic Acid TransportersIBA 11/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	palmitoleic acidIBA 01/2020
1	PutrescineIBA 01/2020
1	glucokinase regulatory proteinIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 10/2019
1	1,5-anhydroglucitolIBA 10/2019
1	Isoleucine (L-Isoleucine)FDA Link 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	CytokinesIBA 01/2019
1	Fenofibrate (CiL)FDA LinkGeneric 08/2018
1	2-hydroxybutyric acidIBA 08/2018
1	AdiponectinIBA 01/2018
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2017
1	EstersIBA 01/2017
1	Poly AIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Ribosomal RNAIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Viral RNAIBA 11/2016
1	ArsenicIBA 01/2016
1	Protons (Proton)IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Pyruvic Acid (Pyruvate)IBA 01/2016
1	arseniteIBA 01/2016

Therapy/Procedure

3	Therapeutics 06/2014 - 03/2010
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 08/2018